How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.
- DOI
- 10.1136/ijgc-2024-005982
- Published
- 2024 Nov 4
- Container
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/ijgc-2024-005982,
title = {How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.},
author = {Sehouli J and Boer J and Brand AH and Oza AM and O'Donnell J and Bennett K and Glaspool R and Lee CK and Ethier JL and Harter P and Seebacher-Shariat V and Chang TC and Cohen PA and van Gorp T and Chavez-Blanco A and Welch S and Hranovska H and O'Toole S and Lok CAR and Madariaga A and Rauh-Hain JA and Perez Fidalgo A and Tan D and Michels J and Pothuri B and Fujiwara N and Rosengarten O and Nishio H and Kim SI and Mukopadhyay A and Piovano E and Cecere SC and Kohn EC and Mukherjee U and Nasser S and Lindemann K and Croke J and Chen X and Geissler F and Bookman MA},
year = {2024},
journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
doi = {10.1136/ijgc-2024-005982},
url = {https://doi.org/10.1136/ijgc-2024-005982}
}RIS
TY - JOUR TI - How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting. AU - Sehouli J AU - Boer J AU - Brand AH AU - Oza AM AU - O'Donnell J AU - Bennett K AU - Glaspool R AU - Lee CK AU - Ethier JL AU - Harter P AU - Seebacher-Shariat V AU - Chang TC AU - Cohen PA AU - van Gorp T AU - Chavez-Blanco A AU - Welch S AU - Hranovska H AU - O'Toole S AU - Lok CAR AU - Madariaga A AU - Rauh-Hain JA AU - Perez Fidalgo A AU - Tan D AU - Michels J AU - Pothuri B AU - Fujiwara N AU - Rosengarten O AU - Nishio H AU - Kim SI AU - Mukopadhyay A AU - Piovano E AU - Cecere SC AU - Kohn EC AU - Mukherjee U AU - Nasser S AU - Lindemann K AU - Croke J AU - Chen X AU - Geissler F AU - Bookman MA PY - 2024 JO - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society DO - 10.1136/ijgc-2024-005982 UR - https://doi.org/10.1136/ijgc-2024-005982 ER -
APA
J, S., J, B., AH, B., AM, O., J, O., K, B., R, G., CK, L., JL, E., P, H., V, S., TC, C., PA, C., T, V. G., A, C., S, W., H, H., S, O., CAR, L., A, M., JA, R., A, P. F., D, T., J, M., B, P., N, F., O, R., H, N., SI, K., A, M., E, P., SC, C., EC, K., U, M., S, N., K, L., J, C., X, C., F, G., & MA, B. (2024). How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1136/ijgc-2024-005982
Source records
- pubmed · retrieved 2026-09-26T04:32:48.400Z